Belimed AG

Belimed AG

Grienbachstrasse 11

6300Zug

    • Rechtsform:

    • Aktiengesellschaft
    • Status:

    • aktiv

    • Kapitalisierung:

    • CHF 6'500'000
    • Gründungsjahr:

    • 1946

    • Bisnode ID:

    • 501747

    • D-U-N-S® Nr.:

    • 48-003-0261

Nachfolgend sowie unter den weiteren Menüpunkten finden Sie alle wichtigen Informationen über die Belimed AG. Neben öffentlichen Daten finden Sie auch Informationen zu Zahlungserfahrungen, Geschichte, Firmenstruktur und Finanzen sowie zur Vernetzung der verantwortlichen Personen.

Schauen Sie genauer hin!

screen_bonitaetsauskunft

Bonität & Betreibungen

Mehr zur Zahlungsfähigkeit erfahren und Überraschungen vermeiden.

Kostenlose Firmen-Überwachung

Wir informieren Sie über wichtige Änderungen.

Handelsregister

    • Handelsregistereintrag:

    • 30.01.1963

    • Rechtlicher Sitz:

    • 6300 Zug

    • HR-Nummer:

    • CH-100.3.006.196-2

    • UID:

    • CHE-105.929.961

    • HR-Amt:

    • Kanton Zug

    • Revisionsstelle:

    • Ernst & Young AG

    • Handelsregisterauszug:

    • Sehen Sie sich hier den original Internet-Auszug zur Belimed AG aus dem zuständigen Handelsregister (HR) an.

      Handelsregisterauszug online

NEU Bewertungen

0 / 5)

Zur Firma Belimed AG liegen noch keine Bewertungen vor.

Firma bewerten

Porträt

    • Infos aus erster Hand:

    • Die Belimed AG hat noch kein Porträt auf monetas erfasst.

      Infos zum Porträt

Management & Mitarbeiter

Finanzielles

    • Bonitätsauskunft:

    • Informieren Sie sich hier über die Kreditwürdigkeit, Bonität und Zahlungsfähigkeit der Firma Belimed AG.

      Zur Belimed AG konnten wir das Zahlungsverhalten zu insgesamt 885 Rechnungen auswerten.

      Bonität prüfen
    • Betreibungsauszug:

    • Wir konnten per 26.06.2017 einen Betreibungsauszug einholen.

      Sehen Sie diesen ein erfahren Sie, ob zu diesem Zeitpunkt zur Firma Belimed AG Betreibungen am Register verzeichnet waren oder nicht.

      Betreibungsauskunft bestellen
    • Risiko-Analyse:

    • Sie mögen alle Infos auf einen Blick? In der Risiko-Analyse zur Belimed AG haben Sie Bonität, Score, reelle Zahlungserfahrungen und einen Betreibungsauszug in einem Bericht.

      Risiko-Analyse einsehen
    • Bonitäts-Zertifikat:

    • Firmen, welche über mehrere Jahre eine hohe Bonität ausweisen, können diese mit einer Urkunde bestätigen lassen.

      Bonitäts-Zertifikat

Firmennamen & Kontakt

    • Aktueller Firmenname:

    • Belimed AG

    • Aktuelle Adresse:

    • Grienbachstrasse 11

      6300 Zug

    • Ehemalige Namen:

    • Belimed Produktions AG (bis 25.05.2005)

      F. Gehrig AG (bis 18.05.2005)

      F. Gehrig & Co. AG (bis 02.05.1997)

Tätigkeit

    • Firmenzweck:

    • Beteiligung im In- und Ausland an Fabrikations- und Handelsunternehmen der Apparate-, Metall- und Kunststoffbranche vorwiegend im Medizin- und Pharmabereich, Herstellung und Handel mit sonstigen Apparaten, insbesondere solchen der Hauswirtschaft und der gewerblichen Reinigungstechnik sowie Erbringung von Dienstleistungen, insbesondere auf dem Sektor Service und auf dem Gebiet des geistigen und gewerblichen Schutzbereiches; kann sich an anderen Unternehmungen beteiligen oder solche finanzieren sowie Grundstücke und Liegenschaften erwerben.

    • Branche(n):

    • Grosshandel mit sonstigen Maschinen und Ausrüstungen

      Finanzholdinggesellschaften

      Sonstige Herstellung von Maschinen für sonstige bestimmte Wirtschaftszweige a. n. g.

      Herstellung von medizinischen und zahnmedizinischen Apparaten und Materialien

      Grosshandel mit medizinischen, chirurgischen und orthopädischen Erzeugnissen

      Grosshandel mit sonstigen Gebrauchs- und Verbrauchsgütern a. n. g.

    • NOGA 2008:

    • 466900, 642001, 289902, 325001, 464602, 464906

Verbindungen

    • Tochtergesellschaften:

    • Im Ausland

    • Niederlassungen:

News

Net income 2017 impacted by extraordinary ex-penses and investments for the future

22.03.2018

Zug, March 22, 2018 – The Metall Zug Group is currently undergoing a period of transfor-mation. Initiatives involving product and process digitization in all Business Units, the stra-tegic modernization of the Zug production site in the Household Appliances Business Unit, further restructuring measures required at Belimed and the structural expansion at Schleuniger resulted in additional expenses. While gross sales remained stable at CHF 959.2 million, operating income (EBIT) fell to CHF 53.0 million in 2017 (previous year: CHF 94.1 million). The financial result climbed to CHF 30.4 million (previous year: CHF 10.3 mil-lion). Net income came to CHF 67.7 million in the reporting year (previous year: CHF 84.9 million).
Although the Metall Zug Group generated stable gross sales of CHF 959.2 million (previous year: CHF 960.6 million), sales declined by 1.0% organically and in local currencies, taking into account the impact of acquisitions and currencies of +0.8% and +0.1% respectively.
Various expenses in relation to digitization and Industry 4.0, product development and structural expansion in all three Business Units, and extraordinary expenses for further restructuring measures at Belimed again had a negative impact on the result. The operating income (EBIT) reported by the Metall Zug Group fell to CHF 53.0 million (previous year: CHF 94.1 million). On a like-for-like basis, i.e. leaving aside the extraordinary expense of CHF 20.8 million in connection with the restructuring measures at Belimed, the 2017 figure actually fell to CHF 73.8 million (pre-vious year: CHF 89.0 million, factoring out the CHF 5.1 million gain on the sale of property).
The pleasing performance of securities increased the financial result to CHF 30.4 million (previous year: CHF 10.3 million). This resulted in net income of CHF 67.7 million (previous year: CHF 84.9 million).
The equity ratio rose to 77.4% of total assets (previous year: 76.9%). The net cash position reached CHF 525.1 million at the end of the reporting year (previous year: CHF 543.0 million).
Household Appliances: Sales Present a Mixed Picture
V-ZUG, whose production facilities are mostly based in Switzerland, was able to improve its mar-ket position again in a declining domestic market despite recording a slight drop in sales. The selective expansion of its own-brand business abroad led to further strong growth. Business in China and Hong Kong proved particularly successful. The sales generated through the OEM part-ner in the US failed to match the prior year’s high level.
The decline in sales, expenses related to the strategic modernization of the Zug production site and to Industry 4.0, and a wide variety of product development initiatives adversely affected the profitability of the Household Appliances Business Unit.
Gross sales of the Household Appliances Business Unit were down 2.0% to CHF 587.4 million
(previous year: CHF 599.2 million). Operating income (EBIT) fell 14.8% to CHF 65.4 million (previous
year: CHF 76.8 million).
Infection Control: Further Restructuring in the Life Science Business Area
The Infection Control Business Unit experienced an unexpected downturn in sales in the second
half of 2017. Delivery problems among suppliers of core components and production delays following
the rollout of SAP in Grosuplje (Slovenia) and Mühldorf (Germany) meant that various
projects in the seasonally important fourth quarter could no longer be delivered on time. Gross
sales fell by 6.1% to CHF 193.4 million (previous year: CHF 206.1 million).
Alongside this sales performance, the Life Science Business Area also had a negative impact on
the Infection Control Business Unit’s operating income. The Medical Business Area had been the
focus of the restructuring measures to date; now it is the turn of the Life Science Business Area
to undergo comprehensive restructuring.
The operating income (EBIT) of CHF –34.2 million (previous year: CHF –6.3 million including a
gain of CHF 5.1 million on the sale of the property in Ballwil) includes the recognition of provisions
for restructuring and impairments totaling CHF 18.0 million in the Life Science Business Area. In
addition, an impairment of CHF 2.8 million had to be recognized in the Corporate reporting segment
for a property used by Belimed.
Wire Processing: High Growth, Expanded Service Range and Strengthened Structures
Schleuniger generated significant growth in sales in the reporting year. The new Software Business
Area, featuring DilT AG (Germany), also contributed to this growth. Schleuniger increased
its gross sales by 14.1% to CHF 180.5 million (previous year: CHF 158.2 million). Operating income
(EBIT) was down 2.2% at CHF 22.3 million (previous year: CHF 22.8 million) due to the
substantial expenses on future growth and integration costs.
In the fourth quarter, Schleuniger signed an agreement to acquire a 60% stake in adaptronic
Prüftechnik GmbH (Germany), thereby adding customized testing solutions to its established
range of services. On January 4, 2018, Schleuniger completed the acquisition.
Visible Transformation of V-ZUG’s Main Site
In parallel with completion of the move into the new “Mistral” production, assembly and development
building, various preparations were made for the next stage in the site’s strategic transformation.
A construction permit was granted for the first build-out phase of the new “Zephyr Hangar”
production facility. The strategic site planning lays the foundations for the company’s long-term
growth, which V-ZUG is seeking to achieve through its selective internationalization strategy. Before
the transformation of the company’s main site into an urban center for technology and innovation
– the planned Technology Cluster Zug – can continue, a legally binding development plan
still needs to be approved. This plan was able to overcome important political hurdles in 2017.
New Business Unit: Medical Devices
On February 28, 2018, the Metall Zug Group completed the acquisition of a 70% stake in Haag-
Streit Holding AG as announced in December 2017. Haag-Streit is a leading medtech company
in the fields of ophthalmology (diagnostics and surgical microscopy), pneumology and precision
optics. The company has become the fourth Business Unit of the Metall Zug Group: Medical Devices.
The Haag-Streit Group generated sales of around CHF 192 million and operating income (EBIT)
of almost CHF 27 million in the 2016 financial year. In the coming years, Metall Zug will invest in
organic growth initiatives and structures at Haag-Streit, as well as look for growth by acquisitions.
Integration costs in the amount of mid-single-digit millions are expected in the current financial
year.
Stable Dividend Distribution
As in the previous year, the Board of Directors will propose to the General Meeting of Shareholders
of May 4, 2018, a dividend in the amount of CHF 7.00 gross per type A registered share and
CHF 70.00 gross per type B registered share.
Outlook
The Metall Zug Group is currently undergoing a period of great transformation. With the groundbreaking
ceremony for the new “Zephyr Hangar” building at the V-ZUG production site in Zug, the
imminent restructuring measures in the Infection Control Business Unit and the additional costs
in relation to Industry 4.0 and product development, the financial year 2018 can be regarded as
another period of transition. The present currency constellation and the rapidly changing operating
conditions brought about by digitalization present additional challenges. At the same time, the
first-time consolidation of Haag-Streit as the fourth Business Unit will lead to a growth spurt. Although
there are various challenges in 2018, the Metall Zug Group has reason to be confident and
cautiously optimistic about the financial year. Assuming that the business environment remains
unchanged, and including Haag-Streit’s contribution to the result as of March 1, 2018, onwards,
the Metall Zug Group expects the 2018 operating income to be significantly above the previous
year’s adjusted operating income (EBIT) of CHF 73.8 million.

Weitere News anzeigen

Nachbarschaft

Firmenprüfzeichen

Zeigen Sie Ihren Website-Besuchern, dass die Firma Belimed AG im Handelsregister eingetragen ist; bauen Sie dazu einfach diesen Code auf Ihrer Webseite ein.

Eintrag editieren

  • Eintrag editieren

  • Haben Sie Ergänzungen oder Korrekturen zum monetas-Eintrag der Belimed AG?

    Eintrag editieren
Inhalt druckenPer E-Mail versenden
  • Login
  • Registrieren
Anzeige
Anzeige